Long-term safety and tolerability of xanomeline and trospium chloride: pooled results from the 52-week, open-label EMERGENT-4 and EMERGENT-5 trials

Neuroscience Applied 2026 Open access

Read full text

Authors: I. Kaul, S. Brannan, S. Sawchak, T. Patel, S. Chaturvedi, A. Pavithran, A. Claxton

DOI: 10.1016/j.nsa.2025.106834

Cited by: 2

Fields of Study & Subjects

Pharmaceutical studies and practices Pharmacology and Obesity Treatment Analytical Methods in Pharmaceuticals